Kingsley Leung

Co-founder and Chairman, Great Bay Bio


For making medicines better

Credit Suisse

In 2019, Kingsley Leung, chairman of traditional pharmaceutical R&D company Uni-Bio Science Group, spotted an opportunity to use AI and robotics to dramatically improve the drug development process. As a result, he spun off a new company, Great Bay Bio, which makes developing new medicines faster and more efficient, potentially reducing both the time it takes and the risks of the process by half.



Social Media

© 2022 Tatler Asia Limited. All rights reserved.
This website uses cookies to improve your experience. See our privacy policy.